So, Alpelisib is a type of drug that targets a specific kind of breast cancer. It’s for those with HR and HER2- breast cancer. This drug goes after something called PI3K signaling, which gets messed up by these PIK3CA mutations.
It comes in three doses—50, 200, and 300 milligrams—as those little film-coated pills. The doc usually suggests you take 300 milligrams a day, with food, if you’re an adult. Each dosage form is supplied in blister packs containing 28 tablets, and the product should be stored at temperatures not exceeding 25C (77F) and protected from light.
